The Ventral Hernia Mesh Devices Market was valued at USD 839.5 million in 2024, and is projected to reach USD 1.35 billion by 2030, rising at a CAGR of 8.48%. The increasing cases of hernias, technological advancements in mesh repair, a shift towards preventive healthcare, and a growing preference for minimally invasive procedures are the factors affecting the market's growth.
There is a significant rise in the number of skin cancer cases globally, which drives the need for advanced solutions to facilitate better cancer care. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.
Hernia repair is one of the most common surgical procedures performed worldwide. The incidence of hernia is higher in men than in women. According to Verywell Health, approximately 20% of adults will develop a primary ventral hernia, which is expected to rise to about 30% following surgery. This disorder is associated with risk factors such as obesity, smoking, unhealthy lifestyle, and age. About 75% of all hernias occur in the groin in adults each year, leading to an increase in the adoption of hernia repair devices. The high incidence of hernia is boosting the demand for efficient hernia repair, which is expected to fuel the market growth.
The International Surgery Journal also reports that incisional and para-umbilical hernias represent 85% of all ventral hernias. Moreover, umbilical hernias are more prevalent in males (65%) than females (35%), primarily because congenital umbilical hernias are less common in females.
As the global population ages, a larger pool of people at higher risk for hernias exists. This led to a rise in reported cases, even if the actual incidence per capita remains stable. Advancements in medical imaging, like ultrasounds and CT scans, make it easier and more common to detect hernias, even those without symptoms. This leads to an impression of increased prevalence as previously undetected cases are now being identified. Certain lifestyle choices can also increase the risk of developing a hernia. These include obesity, chronic cough, and heavy lifting. In addition, public health campaigns and readily available medical information make people more aware of hernias and their symptoms. This led to more people seeking medical attention and getting diagnosed, contributing to a perceived rise in cases.
High incidence of hernia globally and improved patient outcomes by using meshes, which reduce operative and recovery time, are some factors expected to propel market growth. Some advantages of using meshes in hernia repair are alleviating pain and reducing the chances of recurrence. For instance, according to data published by Northeast Georgia Health System, using mesh in hernia repairs can reduce the chances of recurrence by up to 50%. In the U.S., the standard practice is employing mesh for ventral, incisional, and inguinal hernia repairs.
In addition, mesh repair devices are elastic and have an adaptable shape that matches the changing dynamics of the abdominal walls. The large pores in the mesh allow lower foreign body reaction and better & faster soft tissue ingrowth, resulting in flexible scar formation. Thus, these benefits of using mesh in hernia surgeries are anticipated to promote market growth.
Mesh can be used in both open and laparoscopic surgery. Laparoscopic procedures with mesh offer faster recovery times, less pain, and smaller incisions than traditional open repairs without mesh, thereby surging market demand for hernia mesh devices.
Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and non-absorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. For instance, in March 2024, Deep Blue Medical Advances, Inc. introduced the T-Line Hernia Mesh, which helps prevent the recurrence of hernias after abdominal hernia repair surgery.
This product will be delivered within 1-3 business days.
There is a significant rise in the number of skin cancer cases globally, which drives the need for advanced solutions to facilitate better cancer care. According to the U.S. FDA, over a million hernia repair procedures are performed annually in the U.S.
Hernia repair is one of the most common surgical procedures performed worldwide. The incidence of hernia is higher in men than in women. According to Verywell Health, approximately 20% of adults will develop a primary ventral hernia, which is expected to rise to about 30% following surgery. This disorder is associated with risk factors such as obesity, smoking, unhealthy lifestyle, and age. About 75% of all hernias occur in the groin in adults each year, leading to an increase in the adoption of hernia repair devices. The high incidence of hernia is boosting the demand for efficient hernia repair, which is expected to fuel the market growth.
The International Surgery Journal also reports that incisional and para-umbilical hernias represent 85% of all ventral hernias. Moreover, umbilical hernias are more prevalent in males (65%) than females (35%), primarily because congenital umbilical hernias are less common in females.
As the global population ages, a larger pool of people at higher risk for hernias exists. This led to a rise in reported cases, even if the actual incidence per capita remains stable. Advancements in medical imaging, like ultrasounds and CT scans, make it easier and more common to detect hernias, even those without symptoms. This leads to an impression of increased prevalence as previously undetected cases are now being identified. Certain lifestyle choices can also increase the risk of developing a hernia. These include obesity, chronic cough, and heavy lifting. In addition, public health campaigns and readily available medical information make people more aware of hernias and their symptoms. This led to more people seeking medical attention and getting diagnosed, contributing to a perceived rise in cases.
High incidence of hernia globally and improved patient outcomes by using meshes, which reduce operative and recovery time, are some factors expected to propel market growth. Some advantages of using meshes in hernia repair are alleviating pain and reducing the chances of recurrence. For instance, according to data published by Northeast Georgia Health System, using mesh in hernia repairs can reduce the chances of recurrence by up to 50%. In the U.S., the standard practice is employing mesh for ventral, incisional, and inguinal hernia repairs.
In addition, mesh repair devices are elastic and have an adaptable shape that matches the changing dynamics of the abdominal walls. The large pores in the mesh allow lower foreign body reaction and better & faster soft tissue ingrowth, resulting in flexible scar formation. Thus, these benefits of using mesh in hernia surgeries are anticipated to promote market growth.
Mesh can be used in both open and laparoscopic surgery. Laparoscopic procedures with mesh offer faster recovery times, less pain, and smaller incisions than traditional open repairs without mesh, thereby surging market demand for hernia mesh devices.
Technological advancements in hernia mesh devices have significantly improved patient outcomes and reduced complications. One notable innovation is the development of lightweight and composite meshes. These meshes, such as Parietex Composite Mesh, combine absorbable and non-absorbable materials, providing strength while reducing postoperative discomfort and the risk of chronic pain. For instance, in March 2024, Deep Blue Medical Advances, Inc. introduced the T-Line Hernia Mesh, which helps prevent the recurrence of hernias after abdominal hernia repair surgery.
Global Ventral Hernia Mesh Devices Market Report Segmentation
This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For the purpose of this study, the analyst has segmented the ventral hernia mesh devices market report on the basis of mesh type, indication, procedure, end use, and region:Mesh Type Outlook (Revenue, USD Million, 2018-2030)
- Resorbable Mesh
- Partially Absorbable Mesh
- Non-resorbable Mesh
Indication Outlook (Revenue, USD Million, 2018-2030)
- Umbilical Hernia
- Epigastric Hernia
- Incisional Hernia
- Others
Procedure Outlook (Revenue, USD Million, 2018-2030)
- Open Surgery
- Laparoscopic Surgery
- Robotic Surgery
- Others
End Use Outlook (Revenue, USD Million, 2018-2030)
- Inpatient Facilities
- Outpatient Facilities
Region Outlook (Revenue, USD Million, 2018-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Ventral Hernia Mesh Devices Market Variables, Trends & Scope
Chapter 4. Ventral Hernia Mesh Devices Market: Mesh Type Estimates & Trend Analysis
Chapter 5. Ventral Hernia Mesh Devices Market: Indication Estimates & Trend Analysis
Chapter 6. Ventral Hernia Mesh Devices Market: Procedure Estimates & Trend Analysis
Chapter 7. Ventral Hernia Mesh Devices Market: End Use Estimates & Trend Analysis
Chapter 8. Ventral Hernia Mesh Devices Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Ventral Hernia Mesh Devices market report include:- Medtronic plc
- Becton, Dickinson and Company (BD)
- Ethicon Inc. (Johnson & Johnson MedTech)
- Meril Life Sciences Pvt. Ltd.
- Novus Scientific AB
- B. Braun SE
- TELA Bio, Inc.
- BG Medical LLC
- Integra LifeSciences Corporation
- W. L. Gore & Associates, Inc.
- Atrium Medical
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 195 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 839.5 Million |
Forecasted Market Value ( USD | $ 1350 Million |
Compound Annual Growth Rate | 8.4% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |